Dengue virus infection
- aExecutive Director, Zeenat Qureshi Stroke Institute, St. Cloud, MN, United States
- bProfessor, Department of Neurology at University of Missouri, Columbia, United States
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
Abstract The World Health Organization website states “Dengue is a mosquito-borne viral disease that has rapidly spread in all regions of World Health Organization in recent years”. In April 2016, World Health Organization issued a conditional recommendation on the use of the vaccine for areas, in which Dengue virus infection is highly endemic, which is defined by population seroprevalence of 70% or higher. Health officials in the Philippines in July 2019 declared a national emergency after a record-breaking 106,630 cases of Dengue fever were reported since January 2019. The World Health Organization (WHO) estimates that 50–100 million Dengue infections occur each year and that almost half the world's population lives in countries where dengue is endemic. This chapter gives a brief introduction into the current Dengue virus epidemic, the role international organizations are playing to prevent spread and future need for more research in treatment and vaccination options.
TL;DRThis chapter gives a brief introduction into the current Dengue virus epidemic, the role international organizations are playing to prevent spread and future need for more research in treatment and vaccination options. (Semantic Scholar)

